業績紹介 2015年

Ozaki Y, Kawai T, Ismail TF, Ohta M, Okumura M, Takahashi H, Muramatsu T, Umeda H, Murohara T.
Fate and clinical significance of angiographically visible stent malapposition (peri-stent contrast staining) after drug-eluting stent implantation: an long-term clinical follow-up study.
Asiaintervention. 2015; 1(1): 48-56.

Nagao S, Watanabe H, Sobue Y, Kodama M, Tanaka J, Tanabe N, Suzuki E, Narita I, Watanabe E, Aizawa Y, Minamino T.
Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis.
Int J Cardiol. 2015; 189: 1-5.

Tagaya M, Yoshikawa D, Sugishita Y, Yamauchi F, Ito T, Kamada T, Yoshinaga M, Mukaide D, Fujiwara W, Yokoi H, Hayashi M, Watanabe E, Ishii J, Ozaki Y, Izawa H.
Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
Heart Vessels 2015 (in press).

Chishaki A, Kumagai N, Takahashi N, Saikawa T, Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Sakurai M, Kawamura Y, Kubota I, Matsumoto K, Kaneko Y, Ogawa S, Aizawa Y, Chinushi M, Kodama I, Watanabe E, Koretsune Y, Okuyama Y, Shimizu A, Igawa O, Bando S, Fukatani M.
Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM Registry.
Thromb Res. 2015; 136(2): 267-73.

Kini AS, Motoyama S, Vengrenyuk Y, Feig JE, Pena J, Baber U, Bhat AM, Moreno P, Kovacic JC, Narula J, Sharma SK.
Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention.
JACC Cardiovasc Interv. 2015; 8(7): 937-45.

Motoyama S, Ito H, Sarai M, Kondo T, Kawai H, Nagahara Y, Harigaya H, Kan S, Anno H, Takahashi H, Naruse N, Ishii J, Hecht H, Shaw LJ, Ozaki Y, Narula J.
Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-term Follow-up.
J Am Coll Cardiol. 2015; 66(4): 337-46.

Kawai H, Watanabe E, Yamamoto M, Harigaya H, Sano K, Takatsu H, Muramatsu T, Naruse H, Sobue Y, Motoyama S, Sarai M, Takahashi H, Arakawa T, Kan S, Sugiura A, Murohara T, Ozaki Y.
Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting.
J Cardiol. 2015; 65(3): 197-202.

Kawai H, Takakuwa Y, Naruse H, Sarai M, Motoyama S, Ito H, Iwase M, Ozaki Y.
Two cases with past Kawasaki disease developing acute myocardial infarction in their thirties, despite being regarded as at low risk for coronary events.
Heart Vessels. 2015; 30(4): 549-53.

Sobue Y, Harada M, Koshikawa M, Ichikawa T, Yamamoto M, Okuda K, Kato Y, Sarai M, Watanabe E, Ozaki Y
QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
Heart Rhythm. 2015; 12(12): 2499-507.

Watanabe E, Kiyono K, Hayano J, Yamamoto Y, Inamasu J, Yamamoto M, Ichikawa T, Sobue Y, Harada M, Ozaki Y.
Multiscale Entropy of the Heart Rate Variability for the Prediction of an Ischemic Stroke in Patients with Permanent Atrial Fibrillation.
PLoS One. 2015; 10(9): e0137144.

Ozaki Y, Ohta M, Ismail TF, Okumura M, Ishikawa M, Muramatsu T.
Thin Cap Fibroatheroma Defined as Lipid Core Abutting Lumen (LCAL) on Integrated Backscatter Intravascular Ultrasound.-Comparison With Optical Coherence Tomography and Correlation With Peri-Procedural Myocardial infarction.
Circ J. 2015; 79(4): 808-17.

Harada M, Tadevosyan A, QiX, Xiao J, Liu T, Voight N, Karck M, Kamler M, Kodama I, Morohara T, Dobrev D, Nattel S.
Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression.
J Am Coll Cardiol. 2015; 66(1): 47-58.

Qi XY, Huang H, Ordog B, Luo X, Naud P, Sun Y, Wu CT, Dawson K, Tadevosyan A, Chen Y, Harada M, Dobrev D, Nattel S.
Fibroblast inward-rectifier potassium current upreglation in profibrillatory atrial remodeling.
Circ Res. 2015; 116(5): 836-45.

Kini AS, Vengrenyuk Y, Pena J, Motoyama S, Feig JE, Meelu OA, Rajamanickam A, Bhat AM, Panwar S, Baber U, Sharma SK.
Optical coherence tomography assessment of the mechanistic effects of rotational and orbital atherectomy in severely calcified coronary lesions.
Catheter Cardiovasc Interv. 2015; 86(6):1024-32.

Maeda Y, Suzuki A, Ishii J, Sekiguchi-Ueda S, Shibata M, YoshinoY, Asano S, Hayakawa N, Nakamura K, Akiyama Y, Kitagawa F, Sakuishi T, Fujita T, Hashimoto S, Ozaki Y, Ito M.
Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
Heart Vessels. 2015; 30(3): 362-8.

Ishii J, Takahashi H, Kitagawa F, Kuno A, Okuyama R, Kawai H, Muramatsu T, Naruse H, Motoyama S, Matsui S, Hasegawa M, Aoyama T, Kamoi D, Kasuga H, Izawa H, Ozaki Y, Yuzawa Y.
Multimarker approach to risk stratification for long-term mortality in patients on chronic hemodialysis.
Circ J. 2015;79(3):656-63.

Furuhashi M, Hiramitsu S, Mita T, Fuseya T, Ishimura S, Omori A, Matsumoto M, Watanabe Y, Hoshina K, Tanaka M, Moniwa N, Yoshida H, Ishii J, Miura T.
Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.
J Lipid Res. 2015; 56(12):2372-80.

Furuhashi M, Hiramitsu S , Mita T , Omori A, Fuseya T, Ishimura S, Watanabe Y, Hoshina K, Matsumoto M, Tanaka M, Moniwa N, Yoshida H, Ishii J, Miura T.
Reduction of circulating FABP4 level by 3 treatment with omega-3 fatty acid ethyl 4 esters. Lipids Health Dis. 2015; 15(1): 5.

Yoshinaga M, Yoshikawa D, Ishii H, Hirashiki A, Okumura T, Kubota A, Sakai S, Harada K, Somura F, Mizuno T, Fujiwara W, Yokoi H, Hayashi M, Ishii J, Ozaki Y, Murohara T, Yoshida Y, Amano T, Izawa H.
Clinical Characteristics and Long-Term Outcomes of Hypertrophic Cardiomyopathy.
Int Heart J. 2015; 56(4): 415-20.

Kotani K, Ishii J.
High-sensitivity cardiac troponin I in the clinical setting: a rapidly developing field.
Ann Clin Biochem. 2015; 52(Pt 3): 414.

Hosoda T, Wakuda M, Ishii J, Tsuge I, Matsui M, Suzuki S, Yamada K, Suzuki K, Ishikawa K, Yoshida S.
Emergence of Salmonella strain that produces IMP-1-type metallo-β-lactamase in a Japanese patient.
Jpn J Infect Dis. 2015; 68(1): 75-6.

Mita T, Furuhashi M, Hiramitsu S, Ishii J, Hoshina K, Ishimura S, Fuseya T, Watanabe Y, Tanaka M, Ohno K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T.
FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.
Obesity (Silver Spring). 2015; 23(2): 359-67.

Stewart GM, Yamada A, Haseler LJ, Kavanagh JJ, Koerbin G, Chan J, Sabapathy S.
Altered ventricular mechanics after 60 min of high-intensity endurance exercise: insights from exercise speckle-tracking echocardiography.
Am J Physiol Heart Circ Physiol. 2015; 308(8): H875-83.

Ishibashi Y, Muramatsu T, Nakatani S, Sotomi Y, Suwannasom P, Grundeken MJ, Cho YK, Garcia-Garcia HM, van Boven AJ, Piek JJ, Sabaté M, Helqvist S, Baumbach A, McClean D, de Sousa Almeida M, Wasungu L, Miquel-Hebert K, Dudek D, Chevalier B, Onuma Y, Serruys PW.
Incidence and potential mechanism(s) of post-procedural rise of cardiac biomarker in patients with coronary artery narrowing after implantation of an everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent.
JACC Cardiovasc Interv. 2015; 8(8): 1053-63.

Karanasos A, Muramatsu T, Diletti R, Nauta S, Onuma Y, Lenzen M, Nakatani S, van Mieghem NM, Schultz C, de Jaegere PP, Serruys PW, Zijlstra F, Regar E, van Geuns RJ.
Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.
Hellenic J Cardiol. 2015; 56(2): 125-35.

Bourantas CV, Farooq V, Zhang Y, Muramatsu T, Gogas BD, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia HM, Serruys PW.
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial.
Eurointervention. 2015; 10(11): 1299-306.

Nakatani S, OnumaY, Ishibashi Y, Muramatsu T, Iqbal J, Zhang YJ, van Geuns RJ, Ormiston JA, Serruys PW; on behalf of the ABSORB Cohort B investigators.
Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial.
Eurointervention. 2015; 10(11): 1288-98.

Diletti R, Garcia-Garcia HM, Bourantas C, Van Mieghem NM, van Geuns RJ, Muramatsu T, Zhang YJ, Mauri L, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Neumann FJ, Yeung AC, Saito S, Liu M, van Leeuwen F, Serruys PW.
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program.
Catheter Cardiovasc Interv. 2015; 85(6) :952-8.

Yamawaki M, Onuma Y, Nakano M, Muramatsu T, Nakatani S, Ishibashi Y, Ishimori H, Hirano K, Ito Y, Tsukahara R, Muramatsu T.
Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound.
Heart and Vessels. 2015; 30(6): 824-9.

Muramatsu T, Grundeken MJ, Ishibashi Y, Nakatani S, Girasis C, Campos CM, Morel MA, Jonker H, de Winter RJ, Wykrzykowska JJ, García-García HM, Leon MB, Serruys PW, Onuma Y.
Comparison between two- and three-dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trial.
Catheter Cardiocvasc Interv. 2015; 86(3): E140-9.

Onuma Y, Okamura T, Muramatsu T, Uemura S, Serruys PW.
New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI.
Eurointervention. 2015;11 Suppl V:V71-4.

Muramatsu T, García-García HM, Brugaletta S, Heo JH, Onuma Y, Fedewa RJ, Nair A, Ozaki Y, Serruys PW.
Reproducibility of intravascular ultrasound radiofrequency data analysis (Virtual Histology) with a 45 MHz rotational imaging catheter in ex vivo human coronary arteries.
J Cardiol. 2015; 65(2): 134-42.